News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MEDA: Astepro Patent Granted


12/6/2011 6:49:21 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

The United States Patent and Trademark Office (USPTO) today issued a patent related to Astepro (azelastine) nasal spray. This patent will be listed in the FDA's Approved Drug Products List (the Orange Book). The Astepro patent is valid until 2028.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES